These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6149938)

  • 21. The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics.
    Chatterjee SS
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S74-7. PubMed ID: 2439803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High beta 1-selectivity and favourable pharmacokinetics as the outstanding properties of bisoprolol.
    Haeusler G; Schliep HJ; Schelling P; Becker KH; Klockow M; Minck KO; Enenkel HJ; Schulze E; Bergmann R; Schmitges CJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S2-15. PubMed ID: 2439793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential haemodynamic effects induced by beta 1-(bisoprolol) or beta 2-(ICI 118,551) adrenoceptor blockade in man.
    Daul A; Johnston T; Reher M; Krüger M; Brodde OE
    J Hypertens Suppl; 1986 Dec; 4(6):S99-102. PubMed ID: 2886573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical evaluation of bisoprolol in patients with hypertension: interim report.
    Ikeda M; Inagaki Y; Iimura O; Kuramoto K; Takeda T
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S139-42. PubMed ID: 2439785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of two doses of bisoprolol on exercise tolerance in exercise-induced stable angina pectoris.
    de Muinck E; Wagner G; vd Ven LL; Lie KI
    Eur Heart J; 1987 Dec; 8 Suppl M():31-5. PubMed ID: 2897300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-effect relationship and long-term effects of bisoprolol in mild to moderate hypertension.
    Weiner L; Frithz G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S106-12. PubMed ID: 2439780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute changes in renal function induced by bisoprolol, a new cardioselective beta-blocking agent.
    Glück Z; Reubi FC
    Eur J Clin Pharmacol; 1986; 31(1):107-11. PubMed ID: 2877882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive assessment of left ventricular performance after administration of bisoprolol.
    Esper RJ; Esper RC; Burrieza OH; Menna J
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S87-91. PubMed ID: 2439806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac and vascular beta-adrenoceptor-mediated responses before and during treatment with bisoprolol or atenolol.
    Bolli P; Müller FB; Linder L; Ji BH; Bühler FR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S61-4. PubMed ID: 2439800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. beta 1 Selectivity of drugs: quality of the drug or quality of the patient?
    von Wichert P; Perkow I; Teufel W
    Respiration; 1980; 39(6):301-6. PubMed ID: 6106963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.
    Boberg J; Larsen FF; Pehrsson SK
    Clin Cardiol; 1992 Aug; 15(8):591-5. PubMed ID: 1354086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs.
    Schliep HJ; Harting J
    J Cardiovasc Pharmacol; 1984; 6(6):1156-60. PubMed ID: 6084774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
    Daul A; Hermes U; Schäfers RF; Wenzel R; von Birgelen C; Brodde OE
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bisoprolol: a new beta-adrenoceptor blocking drug.
    Prichard BN
    Eur Heart J; 1987 Dec; 8 Suppl M():121-9. PubMed ID: 2897295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bisoprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris.
    Lancaster SG; Sorkin EM
    Drugs; 1988 Sep; 36(3):256-85. PubMed ID: 2903820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antihypertensive effects of bisoprolol during once daily administration in patients with essential hypertension. A dose-ranging study with parallel groups.
    Weiner L; Frithz G
    Eur J Clin Pharmacol; 1986; 29(5):517-21. PubMed ID: 2869951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the effects of bisoprolol and atenolol on lipoprotein concentrations and blood pressure.
    Lithell H; Weiner L; Selinus I; Vessby B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S128-33. PubMed ID: 2439783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure.
    Marazzi G; Iellamo F; Volterrani M; Caminiti G; Madonna M; Arisi G; Massaro R; Righi D; Rosano GM
    Am J Cardiol; 2011 Jan; 107(2):215-9. PubMed ID: 21129714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart rate variability and ischaemia in patients with coronary heart disease and stable angina pectoris; influence of drug therapy and prognostic value. TIBBS Investigators Group. Total Ischemic Burden Bisoprolol Study.
    Weber F; Schneider H; von Arnim T; Urbaszek W
    Eur Heart J; 1999 Jan; 20(1):38-50. PubMed ID: 10075140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bisoprolol in the treatment of chronic stable angina pectoris.
    Terol I; Plaza L; Rodrigo F
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S208-12. PubMed ID: 11527131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.